Brian Mann
-
Two dozen states had hoped to sue the owners of Purdue Pharma for their alleged role in the opioid crisis. But a federal bankruptcy has judge put the brakes on — again — until April 21. -
Attorneys, forensic analysts and other financial experts working for Purdue Pharma spent nearly two years looking for evidence of wrongdoing by the Sacklers. Critics want the findings made public.
-
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.
-
The CDC says hospitals saw a lot more emergency cases involving drug overdoses, as well as mental health crises and suicide attempts. Many emergency departments weren't ready.
-
Four of the biggest American health companies have tentatively agreed to pay $26 billion to settle their opioid liability. Tax breaks could allow them to claw back $4 billion.
-
Lawmakers are blasting the nation's biggest drug makers and distributors for looking to use a pandemic tax-break loophole to write down losses coming from settlements linked to the opioid epidemic.
-
The New York Senate has passed a bill to limit Gov. Andrew Cuomo's emergency powers but the legislation still allows the governor to extend or amend many of his COVID-19 mandates.
-
Black Americans with addiction face "pervasive and continuing systemic racism" and often struggle to gain access to treatments that prevent fatal overdoses.
-
People in Saranac Lake, NY have been building massive palaces out of ice since 1898. It's a folk art that requires a lot of caution and tolerance for bitter cold.
-
Many drug rehab programs use aggressive sales techniques, price-gouge patients and provide substandard care. The system often pushes people struggling with addiction into debt, but not recovery.
